Efficacy and safety of TYK2/JAK1 inhibitor brepocitinib for active psoriatic arthritis
skin.substack.com
Today's report also covers clinical improvement speed in real-world settings, biologic therapy exposure during pregnancy, and more (1,700 words, 8 minutes, 20 seconds)
Efficacy and safety of TYK2/JAK1 inhibitor brepocitinib for active psoriatic arthritis
Efficacy and safety of TYK2/JAK1 inhibitor…
Efficacy and safety of TYK2/JAK1 inhibitor brepocitinib for active psoriatic arthritis
Today's report also covers clinical improvement speed in real-world settings, biologic therapy exposure during pregnancy, and more (1,700 words, 8 minutes, 20 seconds)